Hebei Changshan Biochem Pharma (300255) — Financial Flexibility Index
Hebei Changshan Biochem Pharma (300255) has a Financial Flexibility Index of 0.00x as of September 2025. Free cash flow of CN¥-6.39 Million (operating CF CN¥-30.86 Million minus capex CN¥24.47 Million) represents 0% of total liabilities (CN¥3.18 Billion). Also explore how fast is Hebei Changshan Biochem Pharma growing its equity to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Hebei Changshan Biochem Pharma Financial Flexibility Index (2008–2024)
Historical Financial Flexibility Index trend for Hebei Changshan Biochem Pharma across 17 annual periods. Check Hebei Changshan Biochem Pharma (300255) strategic investment index to assess the company's strategic physical and investment asset allocation.
Annual Financial Flexibility Index for Hebei Changshan Biochem Pharma (2008–2024)
Year-by-year free cash flow to debt coverage for Hebei Changshan Biochem Pharma. For the full company profile including market capitalisation, see 300255 market cap.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.10x | CN¥295.81 Million | CN¥56.22 Million | CN¥2.99 Billion | ▲ +1.4% |
| 2023 | 0.10x | CN¥273.05 Million | CN¥33.73 Million | CN¥2.80 Billion | ▼ -33.0% |
| 2022 | 0.15x | CN¥434.35 Million | CN¥3.13 Million | CN¥2.98 Billion | ▼ -0.8% |
| 2021 | 0.15x | CN¥310.95 Million | CN¥2.87 Million | CN¥2.12 Billion | ▲ +1458.4% |
| 2020 | 0.01x | CN¥16.20 Million | CN¥-183.58 Million | CN¥1.72 Billion | ▼ -89.1% |
| 2019 | 0.09x | CN¥105.28 Million | CN¥-58.13 Million | CN¥1.22 Billion | ▼ -78.4% |
| 2018 | 0.40x | CN¥527.65 Million | CN¥292.81 Million | CN¥1.32 Billion | ▲ +36.3% |
| 2017 | 0.29x | CN¥320.58 Million | CN¥162.28 Million | CN¥1.09 Billion | ▼ -8.1% |
| 2016 | 0.32x | CN¥268.48 Million | CN¥171.96 Million | CN¥842.59 Million | ▲ +411.0% |
| 2015 | 0.06x | CN¥47.20 Million | CN¥-38.14 Million | CN¥757.07 Million | ▼ -41.8% |
| 2014 | 0.11x | CN¥66.24 Million | CN¥-84.97 Million | CN¥617.87 Million | ▼ -84.7% |
| 2013 | 0.70x | CN¥251.96 Million | CN¥-15.24 Million | CN¥359.78 Million | ▲ +274.5% |
| 2012 | 0.19x | CN¥54.75 Million | CN¥-70.62 Million | CN¥292.77 Million | ▼ -21.7% |
| 2011 | 0.24x | CN¥47.47 Million | CN¥17.04 Million | CN¥198.78 Million | ▼ -24.5% |
| 2010 | 0.32x | CN¥66.80 Million | CN¥29.25 Million | CN¥211.25 Million | ▼ -29.8% |
| 2009 | 0.45x | CN¥48.26 Million | CN¥24.21 Million | CN¥107.15 Million | ▲ +259.9% |
| 2008 | -0.28x | CN¥-29.05 Million | CN¥-30.83 Million | CN¥103.16 Million | — |